Clinical Nuclear Medicine

Papers
(The H4-Index of Clinical Nuclear Medicine is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers62
Fibroblast Activation Protein Inhibitor PET/CT61
68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor53
Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI0447
Impact of 18F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer44
Fully Automated Gross Tumor Volume Delineation From PET in Head and Neck Cancer Using Deep Learning Algorithms43
68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient40
COVID-19 mRNA Vaccination–Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT38
Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT37
Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PET37
68Ga-FAPI-04 Accumulation in Myocardial Infarction in a Patient With Neuroendocrine Carcinoma37
68Ga-FAPI Outperforms 18F-FDG PET/CT in Identifying Bone Metastasis and Peritoneal Carcinomatosis in a Patient With Metastatic Breast Cancer36
Comparison of 5 Different PET Radiopharmaceuticals for the Detection of Recurrent Medullary Thyroid Carcinoma35
Decentralized Distributed Multi-institutional PET Image Segmentation Using a Federated Deep Learning Framework34
Sentinel Node Imaging and Radioguided Surgery in the Era of SPECT/CT and PET/CT33
Axillary Lymph Nodes Hypermetabolism After BNT162b2 mRNA COVID-19 Vaccination in Cancer Patients Undergoing 18F-FDG PET/CT32
Increased 68Ga-FAPI Uptake in Chronic Cholecystitis and Degenerative Osteophyte31
99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic Prostate Cancer30
Theranostic Approach in Breast Cancer30
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma29
177Lu-/68Ga-PSMA Theranostics in Recurrent Glioblastoma Multiforme29
Visceral Metastases as Predictors of Response and Survival Outcomes in Patients of Castration-Resistant Prostate Cancer Treated With 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therap28
18F-FDG PET/CT and Serial Chest CT Findings in a COVID-19 Patient With Dynamic Clinical Characteristics in Different Period28
Two Tumors, One Target28
18F-FDG PET and 18F-FDG PET/CT in Vulvar Cancer26
Feasibility of Deep Learning-Guided Attenuation and Scatter Correction of Whole-Body 68Ga-PSMA PET Studies in the Image Domain26
FAPI Uptake in a Vertebral Body Fracture in a Patient With Lung Cancer26
0.041216850280762